Report cover image

U.S. Antibody Specificity Testing Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Antibody Validation & Specificity Testing Services), By Technology, By Application, By End Use – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Oct 01, 2025
SKU # PLRS20566087

Description

The U.S. antibody specificity testing market size is expected to reach USD 729.09 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Antibody Specificity Testing Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Antibody Validation & Specificity Testing Services), By Technology, By Application, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody specificity testing is a process used to check if an antibody correctly binds to its intended target without reacting with other, unrelated molecules. This is an important step in research, diagnostics, and drug development to ensure that antibodies are reliable and produce accurate results. The overall market is a fundamental part of the life science and healthcare industries, driven by the increasing need for high-quality and reliable antibodies for research and clinical use. This need is especially critical in areas such as drug development, where the effectiveness and safety of new therapies depend on the precision of the antibodies used.

The U.S. antibody specificity testing market is growing steadily, mainly because of the rising demand for antibody-based drugs and diagnostic tests. The market is made up of a variety of companies, from large corporations to smaller specialized labs, all providing products and services to ensure antibodies are validated. The market overview shows a strong focus on innovation, with companies constantly working on new technologies and methods to improve the accuracy and speed of testing. This is especially important as the healthcare industry moves toward personalized medicine, where the use of specific and validated antibodies is key to developing effective treatments.

U.S. Antibody Specificity Testing Market Report Highlights:

By product & services, the products segment held the largest share of the market in 2024. Primary and secondary antibodies are essential tools for research and diagnostics. The continuous need for these products in a wide range of scientific and medical applications in the U.S. makes it a dominant segment.

By technology, the immunoassay-based technologies segment held the largest share in 2024. This is due to their long-standing use and reliability in research and clinical labs across the U.S. Techniques such as western blotting and ELISA are standard and widely trusted for detecting specific proteins and other molecules.

By application, the research and development segment held the largest share of the market in 2024. This is because antibody specificity testing is a core part of the drug and antibody discovery and scientific research ecosystem. The significant number of research projects and the high demand for validated antibodies in fields such as genomics and proteomics drive its leading position.

By end use, the pharmaceutical and biotechnology companies segment held the largest share of the market in 2024. The segment is dominated due to increasing innovation and development in antibody-based drugs.

A few key players in the U.S. antibody specificity testing market include Thermo Fisher Scientific; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Abcam plc; Merck KGaA; Becton & Dickinson, Company; Agilent Technologies, Inc.; Danaher Corporation; Bio-Techne Corporation; Cell Signaling Technology, Inc.; and GenScript Biotech Corporation.

Polaris Market Research has segmented the U.S. antibody specificity testing market report based on product & services, technology, application, and end use:

By Product & Services Outlook (Revenue – USD Million, 2020–2034)

Products

Antibody Validation & Specificity Testing Services

By Technology Outlook (Revenue – USD Million, 2020–2034)

Immunoassay-Based Technologies

Genetic Validation-Based Technologies

Microarray-Based Antibody Technologies

Other Technologies

By Application Outlook (Revenue – USD Million, 2020–2034)

Research & Development

Clinical Diagnostics

By End Use Outlook (Revenue – USD Million, 2020–2034)

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Diagnostic Laboratories

Other End Use

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Antibody Specificity Testing Market Insights
4.1. U.S. Antibody Specificity Testing Market – Market Snapshot
4.2. U.S. Antibody Specificity Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Chronic and Infectious Diseases
4.2.1.2. Increased Funding and Research Initiatives
4.2.2. Restraints and Challenges
4.2.2.1. Stringent FDA regulatory requirements
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Antibody Specificity Testing Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. U.S. Antibody Specificity Testing Market, by Products & Services
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Antibody Specificity Testing Market, by Products & Services, 2020–2034 (USD Million)
5.3. Products
5.3.1. U.S. Antibody Specificity Testing Market, by Products, by Region, 2020–2034 (USD Million)
5.4. Antibody Validation & Specificity Testing Services
5.4.1. U.S. Antibody Specificity Testing Market, by Antibody Validation & Specificity Testing Services, by Region, 2020–2034 (USD Million)
6. U.S. Antibody Specificity Testing Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Antibody Specificity Testing Market, by Technology, 2020–2034 (USD Million)
6.3. Immunoassay-based Technologies
6.3.1. U.S. Antibody Specificity Testing Market, by Immunoassay-based Technologies, by Region, 2020–2034 (USD Million)
6.4. Genetic Validation-based Technologies
6.4.1. U.S. Antibody Specificity Testing Market, by Genetic Validation-based Technologies, by Region, 2020–2034 (USD Million)
6.5. Microarray-based Antibody Technologies
6.5.1. U.S. Antibody Specificity Testing Market, by Microarray-based Antibody Technologies, by Region, 2020–2034 (USD Million)
6.6. Other Technologies
6.6.1. U.S. Antibody Specificity Testing Market, by Other Technologies, by Region, 2020–2034 (USD Million)
7. U.S. Antibody Specificity Testing Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Antibody Specificity Testing Market, by Application, 2020–2034 (USD Million)
7.3. Research & Development
7.3.1. U.S. Antibody Specificity Testing Market, by Research & Development, by Region, 2020–2034 (USD Million)
7.4. Clinical Diagnostics
7.4.1. U.S. Antibody Specificity Testing Market, by Clinical Diagnostics, by Region, 2020–2034 (USD Million)
8. U.S. Antibody Specificity Testing Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Antibody Specificity Testing Market, by End Use, 2020–2034 (USD Million)
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. U.S. Antibody Specificity Testing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020–2034 (USD Million)
8.4. Academic & Research Institutes
8.4.1. U.S. Antibody Specificity Testing Market, by Academic & Research Institutes, by Region, 2020–2034 (USD Million)
8.5. Diagnostic Laboratories
8.5.1. U.S. Antibody Specificity Testing Market, by Diagnostic Laboratories, by Region, 2020–2034 (USD Million)
8.6. Other End Use
8.6.1. U.S. Antibody Specificity Testing Market, by Other End Use, by Region, 2020–2034 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abcam plc
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Agilent Technologies, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Becton, Dickinson and Company
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Bio-Techne Corporation
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Cell Signaling Technology, Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Charles River Laboratories International, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Danaher Corporation
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. F. Hoffmann-La Roche AG
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. GenScript Biotech Corporation
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Merck KGaA
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. OriGene Technologies, Inc.
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Thermo Fisher Scientific
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us